Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells

Toru Aizawa, Heng Wei, Joseph M. Miano, Jun ichi Abe, Bradford C. Berk, Chen Yan

Research output: Contribution to journalArticle

Abstract

Atherosclerosis involves cellular immune responses and altered vascular smooth muscle cell (VSMC) function. Nitric oxide (NO)/cGMP is uniquely capable of inhibiting key processes in atherosclerosis. In this study, we determined the effects of NO/cGMP and their molecular mechanisms in the regulation of NF-κB-dependent gene expression in VSMCs. We found that cGMP-elevating agents such as the NO donor S-nitroso-N-acetylpenicillamine (SNAP) and C-type natriuretic peptide (CNP), reduced TNF-α-induced NF-κB-dependent reporter gene expression in rat aortic VSMCs in a cGMP-dependent manner. The effects of SNAP and CNP on NF-κB are mediated by cAMP-dependent protein kinase (PKA) but not cGMP-dependent protein kinase (PKG) based on the findings that the selective PKA inhibitor, PKI, abolished the effects of SNAP and CNP on NF-κB, whereas the PKG inhibitor Rp-8-Br-PET-cGMP had no effect. Inhibition of cGMP-inhibited cAMP-hydrolyzing phosphodiesterase 3 (PDE3) blocked SNAP- and CNP-elicited effects on NF-κB-dependent transcription. Furthermore, cGMP analogues such as 8-pCPT-cGMP, which selectively activates PKG but does not inhibit PDE3, had no effect on NF-κB-mediated transcription. Activation of PKA by SNAP or cAMP-elevating agents not only inhibited TNF-α-induced NF-κB-dependent reporter gene expression but also reduced endogenous NF-κB-dependent adhesion molecule and chemokine expression. These results suggest that SNAP and CNP exert inhibitory effects on NF-κB-dependent transcription by activation of PKA via cGMP-dependent inhibition of PDE3 activity. Therefore, PDE3 is a novel mediator of inflammation in VSMCs.

Original languageEnglish (US)
Pages (from-to)406-413
Number of pages8
JournalCirculation research
Volume93
Issue number5
DOIs
StatePublished - Sep 5 2003
Externally publishedYes

Fingerprint

S-Nitroso-N-Acetylpenicillamine
C-Type Natriuretic Peptide
Phosphoric Diester Hydrolases
Vascular Smooth Muscle
Smooth Muscle Myocytes
Nitric Oxide
Anti-Inflammatory Agents
Cyclic GMP-Dependent Protein Kinases
Reporter Genes
Gene Expression
Atherosclerosis
Inflammation Mediators
Nitric Oxide Donors
Protein S
Protein Kinase Inhibitors
Cyclic AMP-Dependent Protein Kinases
Chemokines
Cellular Immunity
Protein Kinases
Transcriptional Activation

Keywords

  • CGMP
  • Nitric oxide
  • Nuclear factor-κB
  • Phosphodiesterases

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells. / Aizawa, Toru; Wei, Heng; Miano, Joseph M.; Abe, Jun ichi; Berk, Bradford C.; Yan, Chen.

In: Circulation research, Vol. 93, No. 5, 05.09.2003, p. 406-413.

Research output: Contribution to journalArticle

Aizawa, Toru ; Wei, Heng ; Miano, Joseph M. ; Abe, Jun ichi ; Berk, Bradford C. ; Yan, Chen. / Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells. In: Circulation research. 2003 ; Vol. 93, No. 5. pp. 406-413.
@article{6524c3e47dc344179fc9437768fceb17,
title = "Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells",
abstract = "Atherosclerosis involves cellular immune responses and altered vascular smooth muscle cell (VSMC) function. Nitric oxide (NO)/cGMP is uniquely capable of inhibiting key processes in atherosclerosis. In this study, we determined the effects of NO/cGMP and their molecular mechanisms in the regulation of NF-κB-dependent gene expression in VSMCs. We found that cGMP-elevating agents such as the NO donor S-nitroso-N-acetylpenicillamine (SNAP) and C-type natriuretic peptide (CNP), reduced TNF-α-induced NF-κB-dependent reporter gene expression in rat aortic VSMCs in a cGMP-dependent manner. The effects of SNAP and CNP on NF-κB are mediated by cAMP-dependent protein kinase (PKA) but not cGMP-dependent protein kinase (PKG) based on the findings that the selective PKA inhibitor, PKI, abolished the effects of SNAP and CNP on NF-κB, whereas the PKG inhibitor Rp-8-Br-PET-cGMP had no effect. Inhibition of cGMP-inhibited cAMP-hydrolyzing phosphodiesterase 3 (PDE3) blocked SNAP- and CNP-elicited effects on NF-κB-dependent transcription. Furthermore, cGMP analogues such as 8-pCPT-cGMP, which selectively activates PKG but does not inhibit PDE3, had no effect on NF-κB-mediated transcription. Activation of PKA by SNAP or cAMP-elevating agents not only inhibited TNF-α-induced NF-κB-dependent reporter gene expression but also reduced endogenous NF-κB-dependent adhesion molecule and chemokine expression. These results suggest that SNAP and CNP exert inhibitory effects on NF-κB-dependent transcription by activation of PKA via cGMP-dependent inhibition of PDE3 activity. Therefore, PDE3 is a novel mediator of inflammation in VSMCs.",
keywords = "CGMP, Nitric oxide, Nuclear factor-κB, Phosphodiesterases",
author = "Toru Aizawa and Heng Wei and Miano, {Joseph M.} and Abe, {Jun ichi} and Berk, {Bradford C.} and Chen Yan",
year = "2003",
month = "9",
day = "5",
doi = "10.1161/01.RES.0000091074.33584.F0",
language = "English (US)",
volume = "93",
pages = "406--413",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells

AU - Aizawa, Toru

AU - Wei, Heng

AU - Miano, Joseph M.

AU - Abe, Jun ichi

AU - Berk, Bradford C.

AU - Yan, Chen

PY - 2003/9/5

Y1 - 2003/9/5

N2 - Atherosclerosis involves cellular immune responses and altered vascular smooth muscle cell (VSMC) function. Nitric oxide (NO)/cGMP is uniquely capable of inhibiting key processes in atherosclerosis. In this study, we determined the effects of NO/cGMP and their molecular mechanisms in the regulation of NF-κB-dependent gene expression in VSMCs. We found that cGMP-elevating agents such as the NO donor S-nitroso-N-acetylpenicillamine (SNAP) and C-type natriuretic peptide (CNP), reduced TNF-α-induced NF-κB-dependent reporter gene expression in rat aortic VSMCs in a cGMP-dependent manner. The effects of SNAP and CNP on NF-κB are mediated by cAMP-dependent protein kinase (PKA) but not cGMP-dependent protein kinase (PKG) based on the findings that the selective PKA inhibitor, PKI, abolished the effects of SNAP and CNP on NF-κB, whereas the PKG inhibitor Rp-8-Br-PET-cGMP had no effect. Inhibition of cGMP-inhibited cAMP-hydrolyzing phosphodiesterase 3 (PDE3) blocked SNAP- and CNP-elicited effects on NF-κB-dependent transcription. Furthermore, cGMP analogues such as 8-pCPT-cGMP, which selectively activates PKG but does not inhibit PDE3, had no effect on NF-κB-mediated transcription. Activation of PKA by SNAP or cAMP-elevating agents not only inhibited TNF-α-induced NF-κB-dependent reporter gene expression but also reduced endogenous NF-κB-dependent adhesion molecule and chemokine expression. These results suggest that SNAP and CNP exert inhibitory effects on NF-κB-dependent transcription by activation of PKA via cGMP-dependent inhibition of PDE3 activity. Therefore, PDE3 is a novel mediator of inflammation in VSMCs.

AB - Atherosclerosis involves cellular immune responses and altered vascular smooth muscle cell (VSMC) function. Nitric oxide (NO)/cGMP is uniquely capable of inhibiting key processes in atherosclerosis. In this study, we determined the effects of NO/cGMP and their molecular mechanisms in the regulation of NF-κB-dependent gene expression in VSMCs. We found that cGMP-elevating agents such as the NO donor S-nitroso-N-acetylpenicillamine (SNAP) and C-type natriuretic peptide (CNP), reduced TNF-α-induced NF-κB-dependent reporter gene expression in rat aortic VSMCs in a cGMP-dependent manner. The effects of SNAP and CNP on NF-κB are mediated by cAMP-dependent protein kinase (PKA) but not cGMP-dependent protein kinase (PKG) based on the findings that the selective PKA inhibitor, PKI, abolished the effects of SNAP and CNP on NF-κB, whereas the PKG inhibitor Rp-8-Br-PET-cGMP had no effect. Inhibition of cGMP-inhibited cAMP-hydrolyzing phosphodiesterase 3 (PDE3) blocked SNAP- and CNP-elicited effects on NF-κB-dependent transcription. Furthermore, cGMP analogues such as 8-pCPT-cGMP, which selectively activates PKG but does not inhibit PDE3, had no effect on NF-κB-mediated transcription. Activation of PKA by SNAP or cAMP-elevating agents not only inhibited TNF-α-induced NF-κB-dependent reporter gene expression but also reduced endogenous NF-κB-dependent adhesion molecule and chemokine expression. These results suggest that SNAP and CNP exert inhibitory effects on NF-κB-dependent transcription by activation of PKA via cGMP-dependent inhibition of PDE3 activity. Therefore, PDE3 is a novel mediator of inflammation in VSMCs.

KW - CGMP

KW - Nitric oxide

KW - Nuclear factor-κB

KW - Phosphodiesterases

UR - http://www.scopus.com/inward/record.url?scp=0041414284&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041414284&partnerID=8YFLogxK

U2 - 10.1161/01.RES.0000091074.33584.F0

DO - 10.1161/01.RES.0000091074.33584.F0

M3 - Article

C2 - 12919948

AN - SCOPUS:0041414284

VL - 93

SP - 406

EP - 413

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 5

ER -